Pancreastatin--a novel regulatory peptide?

Area of Science:

• Endocrinology
• Neuroendocrinology
• Gastroenterology

Background:

• Pancreastatin is a 49-amino acid peptide derived from chromogranin A, found in secretory granules of endocrine and neuronal cells.
• Its primary structures are conserved across species (70% homology), and it's detected in various organs including the pituitary, adrenal gland, pancreas, CNS, and gastrointestinal tract.
• Pancreastatin co-localizes with key pancreatic hormones like insulin, glucagon, and somatostatin within pancreatic islets.

Purpose of the Study:

• To investigate the biological activities and potential hormonal role of pancreastatin.
• To determine the significance of pancreastatin in the regulation of endocrine and exocrine pancreatic functions.

Main Methods:

• Isolation of pancreastatin from porcine pancreas based on its C-terminal glycinamide.
• Determination of primary structures of human, porcine, bovine, and rat pancreastatin at the protein or cDNA level.
• Immunocytochemical detection of pancreastatin distribution in various tissues.
• Assessment of pancreastatin's effects on insulin release and exocrine pancreatic secretion in different species.

Main Results:

• Pancreastatin's presence was confirmed in multiple endocrine and neuronal tissues, notably co-localizing with pancreatic hormones.
• The peptide was shown to inhibit both insulin release and exocrine pancreatic secretion.
• These inhibitory effects are attributed to the amidated C-terminal portion of the pancreastatin molecule.

Conclusions:

• Pancreastatin exhibits significant biological activities, including the inhibition of insulin and exocrine pancreatic secretion.
• Despite its demonstrated effects, the classification of pancreastatin as a novel peptide hormone with a defined physiological role in pancreatic regulation is still debated.
• Further research is needed to elucidate the exact physiological functions of pancreastatin in the endocrine and exocrine pancreas.